Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults	Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease	Recruiting	Phase 1	2026-06-22		NCT06862453

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Leiden University	13
Sanaria Inc.	6
Stanford University	620
UCLA David Geffen School of Medicine and Fielding School of Public Health	1
University Hospital Tuebingen	123

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Tubingen	Tübingen	Germany	1

Clinical trials